Interaction of catechol and non-catechol substrates with externally or internally facing dopamine transporters

Journal of Neurochemistry

Volumn 109, Issue 4, 2009, Pages 981-994

  Liang, Ying Jian ^b   Zhen, Juan ^b   Chen, Nianhang ^b   Reith, Maarten E A ^a,b  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Binding sidedness; Catechol substrates; Digitonin; Dopamine transporter; Dopamine transporter conformations

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADRENALIN; CATECHOL; COCAINE; DEXAMPHETAMINE; DIGITONIN; DOPAMINE TRANSPORTER; NORADRENALIN; PHENETHYLAMINE; TYRAMINE;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL FREE SYSTEM; CELL MEMBRANE PERMEABILITY; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MUTANT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; WILD TYPE;

BINDING SITES; CATECHOLS; CELL LINE; DIGITONIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; KINETICS; MODELS, MOLECULAR; MUTATION; PERMEABILITY; PROTEIN BINDING; PROTEIN CONFORMATION; SUBSTRATE SPECIFICITY; ZINC;

EID: 65649098434     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06034.x     Document Type: Article

References (60)

1. Amara S. G. Sonders M. S. (1998) Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend. 51, 87 96. (Pubitemid 28353758)
2. Amejdki-Chab N., Costentin J. Bonnet J. J. (1992) Kinetic analysis of the chloride dependence of the neuronal uptake of dopamine and effect of anions on the ability of substrates to compete with the binding of the dopamine uptake inhibitor GBR 12783. J. Neurochem. 58, 793 800.
3. Androutsellis-Theotokis A. Rudnick G. (2002) Accessibility and conformational coupling in serotonin transporter predicted internal domains. J. Neurosci. 22, 8370 8378. (Pubitemid 35387577)
4. Appell M., Berfield J. L., Wang L. C., Dunn III. W. J., Chen N. Reith M. E. (2004) Structure-activity relationships for substrate recognition by the human dopamine transporter. Biochem. Pharmacol. 67, 293 302. (Pubitemid 38112760)
5. Bannon M. J. (2005) The dopamine transporter: role in neurotoxicity and human disease. Toxicol. Appl. Pharmacol. 204, 355 360. (Pubitemid 40545237)
6. Beuming T., Shi L., Javitch J. A. Weinstein H. (2006) A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol. Pharmacol. 70, 1630 1642.
7. Beuming T., Kniazeff J., Bergmann M. L. et al. (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat. Neurosci. 11, 780 789.
8. Bolan E. A., Kivell B., Jaligam V. et al. (2007) D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol. Pharmacol. 71, 1222 1232. (Pubitemid 46661542)
9. Boudanova E., Navaroli D. M., Stevens Z. Melikian H. E. (2008) Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization. Mol. Cell. Neurosci. 39, 211 217.
10. Busch W. Saier Jr. M. H. (2002) The transporter classification (TC) system, 2002. Crit. Rev. Biochem. Mol. Biol. 37, 287 337. (Pubitemid 35333121)
11. Catterall W. A. (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26, 13 25.
12. Chen N. Justice Jr. J. B. (1998) Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: kinetic analysis of inward and outward transport. J. Neurosci. 18, 10257 10268. (Pubitemid 29016545)
13. Chen N. Justice J. B. (2000) Differential effect of structural modification of human dopamine transporter on the inward and outward transport of dopamine. Brain Res. Mol. Brain Res. 75, 208 215. (Pubitemid 30109271)
14. Chen N. Reith M. E. (2004) Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential. J. Neurochem. 89, 750 765. (Pubitemid 38534160)
15. Chen N., Vaughan R. A. Reith M. E. (2001) The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis. J. Neurochem. 77, 1116 1127. (Pubitemid 32467066)
16. Chen N., Sun L. Reith M. E. (2002) Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2 alpha-carbomethoxy-3 alpha-(4-fluorophenyl) tropane. J. Neurochem. 81, 1383 1393.
17. Chen N., Rickey J., Berfield J. L. Reith M. E. (2004a) Aspartate 345 of the dopamine transporter is critical for conformational changes in substrate translocation and cocaine binding. J. Biol. Chem. 279, 5508 5519. (Pubitemid 38220576)
18. Chen N., Zhen J. Reith M. E. (2004b) Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine. J. Neurochem. 89, 853 864. (Pubitemid 38684733)
19. Dunn L. A. Holz R. W. (1983) Catecholamine secretion from digitonin-treated adrenal medullary chromaffin cells. J. Biol. Chem. 258, 4989 4993.
20. Falkenburger B. H., Barstow K. L. Mintz I. M. (2001) Dendrodendritic inhibition through reversal of dopamine transport. Science 293, 2465 2470. (Pubitemid 32917330)
21. Forrest L. R., Zhang Y. W., Jacobs M. T., Gesmonde J., Xie L., Honig B. H. Rudnick G. (2008) Mechanism for alternating access in neurotransmitter transporters. Proc. Natl Acad. Sci. USA 105, 10338 10343.
22. Frye R. A. Holz R. W. (1985) Arachidonic acid release and catecholamine secretion from digitonin-treated chromaffin cells: effects of micromolar calcium, phorbol ester, and protein alkylating agents. J. Neurochem. 44, 265 273. (Pubitemid 15190151)
23. Gainetdinov R. R., Sotnikova T. D. Caron M. G. (2002) Monoamine transporter pharmacology and mutant mice. Trends Pharmacol. Sci. 23, 367 373.
24. Giros B., Jaber M., Jones S. R., Wightman R. M. Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606 612. (Pubitemid 26052818)
25. Goncalves C. A., Gottfried C. Dunkley P. R. (2000) The use of permeabilized cells to assay protein phosphorylation and catecholamine release. Neurochem. Res. 25, 885 894. (Pubitemid 30625521)
26. Gracz L. M. Madras B. K. (1995) [3H]WIN 35,428 ([3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum. J. Pharmacol. Exp. Ther. 273, 1224 1234.
27. Hammarstrom A. K. Gage P. W. (2002) Hypoxia and persistent sodium current. Eur. Biophys. J. 31, 323 330.
28. Jones S. R., Gainetdinov R. R., Wightman R. M. Caron M. G. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979 1986. (Pubitemid 28141404)
29. Khoshbouei H., Sen N., Guptaroy B., Johnson L., Lund D., Gnegy M. E., Galli A. Javitch J. A. (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol. 2, E78. (Pubitemid 39234535)
30. Kitayama S., Shimada S., Xu H., Markham L., Donovan D. M. Uhl G. R. (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl Acad. Sci. USA 89, 7782 7785.
31. Kniazeff J., Shi L., Loland C. J., Javitch J. A., Weinstein H. Gether U. (2008) An intracellular interaction network regulates conformational transitions in the dopamine transporter. J. Biol. Chem. 283, 17691 17701.
32. Levi G. Raiteri M. (1993) Carrier-mediated release of neurotransmitters. Trends Neurosci. 16, 415 419. (Pubitemid 23283403)
33. Li L. B. Reith M. E. (1999) Modeling of the interaction of Na+ and K+ with the binding of dopamine and [3H]WIN 35,428 to the human dopamine transporter. J. Neurochem. 72, 1095 1109.
34. Loland C. J., Desai R. I., Zou M. F., Cao J., Grundt P., Gerstbrein K., Sitte H. H., Newman A. H., Katz J. L. Gether U. (2008) Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Mol. Pharmacol. 73, 813 823.
35. Meiergerd S. M. Schenk J. O. (1994) Striatal transporter for dopamine: catechol structure-activity studies and susceptibility to chemical modification. J. Neurochem. 62, 998 1008. (Pubitemid 24064511)
36. Melikian H. E. Buckley K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 7699 7710. (Pubitemid 30225770)
37. Mortensen O. V., Larsen M. B., Prasad B. M. Amara S. G. (2008) Genetic complementation screen identifies a mitogen-activated protein kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking. Mol. Biol. Cell 19, 2818 2829.
38. Norregaard L., Frederiksen D., Nielsen E. O. Gether U. (1998) Delineation of an endogenous zinc-binding site in the human dopamine transporter. EMBO J. 17, 4266 4273. (Pubitemid 28362617)
39. Parnas M. L., Gaffaney J. D., Zou M. F., Lever J. R., Newman A. H. Vaughan R. A. (2008) Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2beta- carbomethoxy-3beta-(4-chlorophenyl) tropane implicates proximity of cocaine and substrate active sites. Mol. Pharmacol. 73, 1141 1150.
40. Pifl C., Wolf A., Rebernik P., Reither H. Berger M. L. (2008) Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner. Neuropharmacology 56, 531 540.
41. Quick M., Yano H., Goldberg N. R., Duan L., Beuming T., Shi L., Weinstein H. Javitch J. A. (2006) State-dependent conformations of the translocation pathway in the tyrosine transporter Tyt1, a novel neurotransmitter:sodium symporter from Fusobacterium nucleatum. J. Biol. Chem. 281, 26444 26454. (Pubitemid 44401853)
42. Reith M. E. Selmeci G. (1992) Cocaine binding sites in mouse striatum, dopamine autoreceptors, and cocaine-induced locomotion. Pharmacol. Biochem. Behav. 41, 227 230.
43. Reith M. E., de C. B., Rice K. C. Jacobson A. E. (1992) Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter. Eur. J. Pharmacol. 227, 417 425.
44. Rice M. E. Cragg S. J. (2008) Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway. Brain Res. Rev. 58, 303 313.
45. Rothman R. B., Baumann M. H., Dersch C. M., Romero D. V., Rice K. C., Carroll F. I. Partilla J. S. (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39, 32 41.
46. Shi L., Quick M., Zhao Y., Weinstein H. Javitch J. A. (2008) The mechanism of a neurotransmitter:sodium symporter - inward release of Na+ and substrate is triggered by substrate in a second binding site. Mol. Cell 30, 667 677.
47. Singh S. K., Yamashita A. Gouaux E. (2007) Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature 448, 952 956. (Pubitemid 47312772)
48. Sorkina T., Miranda M., Dionne K. R., Hoover B. R., Zahniser N. R. Sorkin A. (2006) RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis. J. Neurosci. 26, 8195 8205. (Pubitemid 44315144)
49. Sugawara T., Tsurubuchi Y., Agarwala K. L. et al. (2001) A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc. Natl Acad. Sci. USA 98, 6384 6389. (Pubitemid 32488246)
50. Swaminath G., Deupi X., Lee T. W., Zhu W., Thian F. S., Kobilka T. S. Kobilka B. (2005) Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J. Biol. Chem. 280, 22165 22171. (Pubitemid 40827872)
51. Tidjane C. A., Do-Rego J. C., Costentin J. Bonnet J. J. (2001) Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes. Neurosci. Res. 39, 319 325. (Pubitemid 32186384)
52. Wang W., Sonders M. S., Ukairo O. T., Scott H., Kloetzel M. K. Surratt C. K. (2003) Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter. Mol. Pharmacol. 64, 430 439. (Pubitemid 36910007)
53. Wilson S. P. Kirshner N. (1983) Calcium-evoked secretion from digitonin-permeabilized adrenal medullary chromaffin cells. J. Biol. Chem. 258, 4994 5000.
54. Wu Q., Coffey L. L. Reith M. E. (1997) Cations affect [3H]mazindol and [3H]WIN 35,428 binding to the human dopamine transporter in a similar fashion. J. Neurochem. 69, 1106 1118. (Pubitemid 27364831)
55. Xhaard H., Backstrom V., Denessiouk K. Johnson M. S. (2008) Coordination of Na(+) by monoamine ligands in dopamine, norepinephrine, and serotonin transporters. J. Chem. Inf. Model 48, 1423 1437.
56. - dependent neurotransmitter transporters. Nature 437, 215 223. (Pubitemid 41294479)
57. Zapata A., Kivell B., Han Y. et al. (2007) Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J. Biol. Chem. 282, 35842 35854. (Pubitemid 350277154)
58. Zhen J., Chen N. Reith M. E. (2005) Differences in interactions with the dopamine transporter as revealed by diminishment of Na(+) gradient and membrane potential: dopamine versus other substrates. Neuropharmacology 49, 769 779. (Pubitemid 41483883)
59. Zhou Z., Zhen J., Karpowich N. K., Goetz R. M., Law C. J., Reith M. E. Wang D. N. (2007) LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 317, 1390 1393. (Pubitemid 47417479)
60. Zimanyi I., Lajtha A. Reith M. E. (1989) Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum. Naunyn Schmiedebergs Arch. Pharmacol. 340, 626 632. (Pubitemid 20023149)